961 related articles for article (PubMed ID: 18597414)
1. Substituted beta-cyclodextrin and calix[4]arene as encapsulatory vehicles for platinum(II)-based DNA intercalators.
Krause-Heuer AM; Wheate NJ; Tilby MJ; Pearson DG; Ottley CJ; Aldrich-Wright JR
Inorg Chem; 2008 Aug; 47(15):6880-8. PubMed ID: 18597414
[TBL] [Abstract][Full Text] [Related]
2. Novel platinum(II)-based anticancer complexes and molecular hosts as their drug delivery vehicles.
Wheate NJ; Taleb RI; Krause-Heuer AM; Cook RL; Wang S; Higgins VJ; Aldrich-Wright JR
Dalton Trans; 2007 Nov; (43):5055-64. PubMed ID: 17992290
[TBL] [Abstract][Full Text] [Related]
3. Side-on binding of p-sulphonatocalix[4]arene to the dinuclear platinum complex trans-[{PtCl(NH3)2}2mu-dpzm]2+ and its implications for anticancer drug delivery.
Wheate NJ; Abbott GM; Tate RJ; Clements CJ; Edrada-Ebel R; Johnston BF
J Inorg Biochem; 2009 Mar; 103(3):448-54. PubMed ID: 19171382
[TBL] [Abstract][Full Text] [Related]
4. Degradation of bidentate-coordinated platinum(II)-based DNA intercalators by reduced L-glutathione.
Kemp S; Wheate NJ; Pisani MJ; Aldrich-Wright JR
J Med Chem; 2008 May; 51(9):2787-94. PubMed ID: 18412325
[TBL] [Abstract][Full Text] [Related]
5. Studies of the mechanism of action of platinum(II) complexes with potent cytotoxicity in human cancer cells.
Krause-Heuer AM; Grünert R; Kühne S; Buczkowska M; Wheate NJ; Le Pevelen DD; Boag LR; Fisher DM; Kasparkova J; Malina J; Bednarski PJ; Brabec V; Aldrich-Wright JR
J Med Chem; 2009 Sep; 52(17):5474-84. PubMed ID: 19658404
[TBL] [Abstract][Full Text] [Related]
6. DNA binding and biological activity of some platinum(II) intercalating compounds containing methyl-substituted 1,10-phenanthrolines.
Brodie CR; Collins JG; Aldrich-Wright JR
Dalton Trans; 2004 Apr; (8):1145-52. PubMed ID: 15252653
[TBL] [Abstract][Full Text] [Related]
7. Proparacaine complexation with beta-cyclodextrin and p-sulfonic acid calix[6]arene, as evaluated by varied (1)H-NMR approaches.
Arantes LM; Scarelli C; Marsaioli AJ; de Paula E; Fernandes SA
Magn Reson Chem; 2009 Sep; 47(9):757-63. PubMed ID: 19557725
[TBL] [Abstract][Full Text] [Related]
8. Anionic PAMAM dendrimers as drug delivery vehicles for transition metal-based anticancer drugs.
Pisani MJ; Wheate NJ; Keene FR; Aldrich-Wright JR; Collins JG
J Inorg Biochem; 2009 Mar; 103(3):373-80. PubMed ID: 19121543
[TBL] [Abstract][Full Text] [Related]
9. Encapsulation of platinum(II)-based DNA intercalators within cucurbit[6,7,8]urils.
Kemp S; Wheate NJ; Wang S; Collins JG; Ralph SF; Day AI; Higgins VJ; Aldrich-Wright JR
J Biol Inorg Chem; 2007 Sep; 12(7):969-79. PubMed ID: 17653578
[TBL] [Abstract][Full Text] [Related]
10. The effect of ancillary ligand chirality and phenanthroline functional group substitution on the cytotoxicity of platinum(II)-based metallointercalators.
Kemp S; Wheate NJ; Buck DP; Nikac M; Collins JG; Aldrich-Wright JR
J Inorg Biochem; 2007 Jul; 101(7):1049-58. PubMed ID: 17544512
[TBL] [Abstract][Full Text] [Related]
11. Design and non-covalent DNA binding of platinum(II) metallacalix[4]arenes.
Galindo MA; Olea D; Romero MA; Gómez J; del Castillo P; Hannon MJ; Rodger A; Zamora F; Navarro JA
Chemistry; 2007; 13(18):5075-81. PubMed ID: 17465426
[TBL] [Abstract][Full Text] [Related]
12. DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.
Novakova O; Chen H; Vrana O; Rodger A; Sadler PJ; Brabec V
Biochemistry; 2003 Oct; 42(39):11544-54. PubMed ID: 14516206
[TBL] [Abstract][Full Text] [Related]
13. Supramolecular nanoencapsulation as a tool: solubilization of the anticancer drug trans-dichloro(dipyridine)platinum(II) by complexation with beta-cyclodextrin.
Horvath G; Premkumar T; Boztas A; Lee E; Jon S; Geckeler KE
Mol Pharm; 2008; 5(2):358-63. PubMed ID: 18281942
[TBL] [Abstract][Full Text] [Related]
14. Intercalation into the DNA double helix and in vivo biological activity of water-soluble planar [Pt(diimine)(N,N-dihydroxyethyl-N'-benzoylthioureato)]+Cl- complexes: a study of their thermal stability, their CD spectra and their gel mobility.
Wu YS; Koch KR; Abratt VR; Klump HH
Arch Biochem Biophys; 2005 Aug; 440(1):28-37. PubMed ID: 16009327
[TBL] [Abstract][Full Text] [Related]
15. DNA binding studies of novel Copper(II) complexes containing L-tryptophan as chiral auxiliary: in vitro antitumor activity of Cu-Sn2 complex in human neuroblastoma cells.
Chauhan M; Banerjee K; Arjmand F
Inorg Chem; 2007 Apr; 46(8):3072-82. PubMed ID: 17378549
[TBL] [Abstract][Full Text] [Related]
16. Does cytotoxicity of metallointercalators correlate with cellular uptake or DNA affinity?
Davis KJ; Carrall JA; Lai B; Aldrich-Wright JR; Ralph SF; Dillon CT
Dalton Trans; 2012 Aug; 41(31):9417-26. PubMed ID: 22740039
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, crystal structure, studies in solution and cytotoxicity of two new fluorescent platinum(II) compounds containing anthracene derivatives as a carrier ligand.
Marqués-Gallego P; den Dulk H; Brouwer J; Kooijman H; Spek AL; Roubeau O; Teat SJ; Reedijk J
Inorg Chem; 2008 Dec; 47(23):11171-9. PubMed ID: 18975941
[TBL] [Abstract][Full Text] [Related]
18. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
Brabec V; Nováková O
Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
[TBL] [Abstract][Full Text] [Related]
19. DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation.
Roy S; Maheswari PU; Lutz M; Spek AL; den Dulk H; Barends S; van Wezel GP; Hartl F; Reedijk J
Dalton Trans; 2009 Dec; (48):10846-60. PubMed ID: 20023915
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic effect, differentiation, inhibition of growth and theoretical calculations of an N,N-donor ligands and its platinum(II), palladium(II) and copper(II) complexes.
Miernicka M; Szulawska A; Czyz M; Lorenz IP; Mayer P; Karwowski B; Budzisz E
J Inorg Biochem; 2008 Feb; 102(2):157-65. PubMed ID: 17868889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
